Restricted accessEditorialFirst published online 2009-05
Editorial: Issues for DSM-V: I) Including Biological Variables To Objectively Comfort the Clinical Diagnosis of Borderline Personality Disorder and II) Proposing a New Subcategory To Be Included in the Criteria Sets for Further Study
De la Fuente, J.M., Goldman, S.L., Stanus, E., Vizuete, C., Morlan, I., Bobes, J. et al. (1997) Brain glucose metabolism in borderline personality disorder. Journal of Psychiatric Research, 31: 531-541.
2.
De la Fuente, J.M., Tugendhaft, P. & Mavroudakis, N. (1998) Electroencephalographic Abnormalities in Borderline Personality Disorder. Psychiatry Research, 7: 131-138.
3.
De la Fuente, J.M., Bobes, J., Vizuete, C. & Mendlewicz, J. (2002) Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. Journal of Psychiatric Research , 36: 137-45.
4.
De la Fuente, J.M., Bobes, J., Morlan, I., Bascaran, M.T., Vizuete, C., Linkowski, P. et al. (2004) Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects . Psychiatry Research, 129: 65-73.
5.
De la Fuente, J.M., Bobes, J., Vizuete, C., Bascaran, M.T., Morlan, I. & Mendlewicz, J. (2006) Neurologic soft signs in borderline personality disorder. Journal of Clinical Psychiatry , 67: 541-546.
6.
Feske, U., Mulsant, B.H., Pilkonis, P.A., Soloff. P., Dolata, D., Sackeim, H.A. et al. (2004) Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. American Journal of Psychiatry, 161: 2073-2080.
7.
First, M.B. & Zimmerman, M. (2006) Including laboratory tests in DSM-V diagnostic criteria. American Journal of Psychiatry, 163: 2041-2042.
8.
McGlashan, T.H., Grilo, C.M., Sanislow, C.A., Ralevski, E., Morey, L.C., Gunderson et al. (2005) Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. American Journal of Psychiatry , 162: 883-889.
9.
Mintun, M.A., Sheline, Y.I., Moerlein, S.M., Vlassenko, A.G., Huang, Y. & Snyder, A.Z. (2004) Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biological Psychiatry, 55: 217-24.
10.
Rogers, J.H., Widiger, T.A. & Krupp, A. (1995) Aspects of depression associated with borderline personality disorder. American Journal of Psychiatry, 152: 268-70.
11.
Soloff, P.H., Price, J.C., Meltzer, C.C., Fabio, A., Frank, G.K. & Kaye, W.H. (2007) 5HT(2A) Receptor Binding Is Increased in Borderline Personality Disorder. Biological Psychiatry, 62: 580-587.
12.
Staner, L., De La Fuente, J.M., Kerkhofs, M., Linkowski, P. & Mendlewicz, J. (1992) Biological and clinical features in recurrent brief depression: A comparation with major depressed and healthy subjects. Journal of Affective Disorders, 26: 241-246.
